Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome

por Fang, Ying, Guo, Juan, Wu, Dong, Wu, Ling-Yun, Song, Lu-Xi, Zhang, Zheng, Zhao, You-Shan, Chang, Chun-Kang
Publicado 2021

Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes

por Fei, Cheng-Ming, Guo, Juan, Zhao, You-Shan, Zhao, Si-Da, Zhen, Qing-Qing, Shi, Lei, Li, Xiao, Chang, Chun-Kang
Publicado 2018

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations

por Li, Xiao, Xu, Feng, Wu, Ling-Yun, Zhao, You-Shan, Guo, Juan, He, Qi, Zhang, Zheng, Chang, Chun-Kang, Wu, Dong
Publicado 2020

Comparative Study on Iron Content Detection by Energy Spectral CT and MRI in MDS Patients

por Zhang, Yao, Xiao, Chao, Li, Jing, Song, Lu-xi, Zhao, You-shan, Han, Shuang, Li, Zhao-wei, Guo, Cha, Zhao, Jun-gong, Chang, Chun-kang
Publicado 2021

Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes

por Xu, Feng, Wu, Ling-Yun, He, Qi, Wu, Dong, Zhang, Zheng, Song, Lu-Xi, Zhao, You-Shan, Su, Ji-Ying, Zhou, Li-Yu, Guo, Juan, Chang, Chun-Kang, Li, Xiao
Publicado 2017

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome

por Xu, Feng, Liu, Li, Chang, Chun-Kang, He, Qi, Wu, Ling-Yun, Zhang, Zheng, Shi, Wen-Hui, Guo, Juan, Zhu, Yang, Zhao, You-Shan, Gu, Shu-Cheng, Fei, Cheng-Ming, Li, Xiao
Publicado 2016

Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome

por Xu, Feng, He, Qi, Li, Xiao, Chang, Chun-Kang, Wu, Ling-Yun, Zhang, Zheng, Liu, Li, Shi, Wen-Hui, Zhu, Yang, Zhao, You-Shan, Gu, Shu-Cheng, Fei, Cheng-Ming, Guo, Juan, Wu, Dong, Zhou, Liyu
Publicado 2014

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

por Xu, Feng, Wu, Ling-Yun, Chang, Chun-Kang, He, Qi, Zhang, Zheng, Liu, Li, Shi, Wen-Hui, Guo, Juan, Zhu, Yang, Zhao, You-Shan, Gu, Shu-Cheng, Fei, Cheng-Ming, Wu, Dong, Zhou, Li-Yu, Su, Ji-Ying, Song, Lu-Xi, Xiao, Chao, Li, Xiao
Publicado 2015